Skip to content
September 19, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Genomics and Precision Medicine
  • The Dawn of Autonomous Discovery: Exploring the Convergence of Agentic AI and Scientific Machine Learning
  • Genomics and Precision Medicine

The Dawn of Autonomous Discovery: Exploring the Convergence of Agentic AI and Scientific Machine Learning

Raul Delapena Setiawan September 18, 2026 7 minutes read
the-dawn-of-autonomous-discovery-exploring-the-convergence-of-agentic-ai-and-scientific-machine-learning

In the rapidly evolving landscape of modern science, the traditional paradigm of the "lone genius" working in isolation is being fundamentally rewritten. Today, the most profound breakthroughs are emerging from a complex, dynamic interplay between human intuition, massive datasets, and sophisticated computational frameworks. As the boundaries between artificial intelligence and empirical research blur, a pivotal question has emerged: Can we move beyond merely using AI to automate routine tasks, and instead leverage it to act as a creative partner capable of generating novel scientific hypotheses?

This question serves as the focal point for an upcoming symposium featuring two preeminent voices in the field: Professor George Karniadakis, a titan of applied mathematics and computational science, and Nazanin Ahmadi, a rising pioneer in biomedical engineering and agentic AI. Their dual presentations will explore how Scientific Machine Learning (SciML) and multi-agent frameworks are poised to usher in a new era of autonomous, interpretable, and high-stakes scientific discovery.


The Core Thesis: Beyond Automation toward Creative Reasoning

The central abstract for the event challenges the prevailing narrative that AI is merely an efficiency tool. Instead, it posits that scientific creativity is a product of interaction—a synthesis of models, physical laws, and collaborative reasoning.

The speakers argue that while current AI systems excel at processing information, they often lack the "scientific intuition" required for true discovery. To bridge this gap, the talk proposes an agentic framework rooted in SciML. Unlike standard black-box AI, SciML marries data-driven learning with the hard constraints of mathematical structure and physical knowledge. By embedding physics-informed neural networks (PINNs) and neural operators into the heart of the computational engine, researchers can ensure that AI-generated models are not only accurate but also physically consistent and interpretable.

The vision presented is one of a "multi-agent ecosystem." In this framework, specialized AI agents are tasked with distinct roles: proposing hypotheses, critiquing models, validating outcomes through mathematical rigor, and iteratively refining explanations. By simulating a community of expert researchers, these agentic systems can traverse vast hypothesis spaces that would be intractable for a human alone.


Chronology of the Symposium

The event is structured to provide both a broad theoretical foundation and a deep dive into practical, real-world applications.

  • 09:00 a.m. – 09:45 a.m.: The Theoretical Engine. George Karniadakis will open the session, providing an authoritative overview of the intersection between SciML and agentic workflows. His talk will focus on the mathematical underpinnings of the systems and the evolution of computational frameworks that allow machines to participate in the scientific method.
  • 10:00 a.m. – 10:50 a.m.: Practical Implementation and Applications. Following a brief intermission, Nazanin Ahmadi will shift the focus to the practical deployment of these agentic frameworks. Her presentation will demonstrate how these theoretical models translate into breakthroughs in systems biology and pharmacology, specifically highlighting her work on physics-informed neural networks.

Supporting Data: The Architects of the Future

George Karniadakis: A Career Defined by Impact

The stature of Professor George Karniadakis in the global scientific community cannot be overstated. An elected member of both the National Academy of Engineering and the National Academy of Arts and Sciences, Karniadakis has spent decades pushing the boundaries of applied and computational mathematics.

His credentials are vast:

  • Academic Pedigree: Holding S.M. and Ph.D. degrees from MIT, he has held faculty appointments at prestigious institutions including Princeton, Caltech, and Brown University.
  • Global Recognition: In 2025, Research.com named him the number one math scientist in the world. His h-index of 171 and over 184,000 citations reflect a career that has fundamentally shaped the field of computational fluid dynamics and beyond.
  • Distinguished Awards: His accolades include the William Benter Prize, the SIAM/ACM Prize on Computational Science & Engineering, and the Alexander von Humboldt award, among many others.

His involvement signals a shift in the mathematical community toward embracing AI as a rigorous discipline rather than a peripheral technological curiosity.

Nazanin Ahmadi: Leading the Next Generation

As a Ph.D. candidate in Biomedical Engineering at Brown University, Nazanin Ahmadi represents the vanguard of researchers who are natively integrating AI into the biological sciences. Her work bridges the gap between abstract neural architectures and the concrete, high-stakes requirements of drug discovery and pharmacometric modeling.

  • Pioneering Research: Ahmadi is recognized for her early and successful application of physics-informed neural networks to pharmacometrics, providing a mechanism-based alternative to traditional, less-interpretable machine learning models.
  • Industry and Academic Acclaim: Her recognition as a winner at the Broad Institute’s Machine Learning in Drug Discovery symposium, coupled with her success in the ASCPT Research Pitch Competition, highlights her ability to communicate complex computational strategies to diverse scientific audiences.

Implications: The Future of Scientific Discovery

The integration of agentic AI into the scientific process has profound implications for how we address humanity’s most complex challenges.

From Pattern Matching to Hypothesis Generation

The primary implication of the work presented by Karniadakis and Ahmadi is the shift from "descriptive" to "generative" science. Traditional machine learning is often used to predict outcomes based on existing data. The agentic framework proposed goes further: it seeks to identify unexplained patterns and propose testable hypotheses that human researchers may have overlooked. By automating the "critique and refine" cycle, these systems act as a force multiplier for the human scientist.

Accelerating Translational Medicine

In fields like systems biology and cancer treatment, the complexity of the data often outpaces the speed of manual analysis. Ahmadi’s research into systems pharmacology demonstrates how agentic AI can navigate the vast, non-linear dynamics of biological systems. By using neural operators that respect physical and biological laws, these models offer a roadmap to understanding how treatments interact with gene-expression trajectories, potentially shortening the timeline from basic research to clinical application.

The Problem of Interpretability

A common critique of AI in science is the "black box" nature of deep learning. The speakers address this head-on by emphasizing "interpretable and mechanistically grounded AI." By constraining neural networks with physics-based equations, the resulting models are not just successful at prediction; they are capable of being audited. This transparency is critical for medical and scientific validation, ensuring that AI-driven discoveries are rooted in reality rather than statistical artifacts.


Official Perspective and Forward Outlook

The symposium serves as a call to action for the broader scientific community to reconsider the role of artificial intelligence. It is not a replacement for human thought, but an evolution of the scientific apparatus.

As Karniadakis and Ahmadi will demonstrate, the future of discovery lies in the synergy between the speed of the machine and the wisdom of the human. When an AI system can propose a hypothesis, a second agent can critique its mathematical validity, and a third can test it against biological constraints, we move into an era of "accelerated iteration."

The event promises to provide a rigorous, forward-looking roadmap for researchers, policymakers, and technologists. It underscores the necessity of building AI systems that are not just "smart," but scientifically literate—systems that understand the laws of the physical world as deeply as they understand the patterns in the data.

For those in attendance, the symposium offers a unique opportunity to witness the next stage of the scientific revolution. By moving beyond the automation of existing tasks, we are finally opening the door to a world where AI serves as a true partner in the quest for fundamental, creative, and transformative scientific discovery.

About the Author

Raul Delapena Setiawan

Author

View All Posts

Post navigation

Previous: Bridging the Gap: How New Research is Reshaping Inclusion in Genetic Biobanks
Next: A Beacon of Hope: Shelly’s Journey Through Breast Cancer, Illuminated by Patient Navigation

Related Stories

the-genetic-imperative-ashg-confronts-the-misuse-of-science-in-the-modern-era-1
  • Genomics and Precision Medicine

The Genetic Imperative: ASHG Confronts the Misuse of Science in the Modern Era

Asep Darmawan September 19, 2026
from-soil-to-sustainable-synthesis-the-genetic-revolution-in-perennial-grasses-1
  • Genomics and Precision Medicine

From Soil to Sustainable Synthesis: The Genetic Revolution in Perennial Grasses

Muslim September 19, 2026
architect-of-immunity-the-scientific-legacy-and-vision-of-marco-colonna
  • Genomics and Precision Medicine

Architect of Immunity: The Scientific Legacy and Vision of Marco Colonna

Ammar Sabilarrohman September 18, 2026

Recent Posts

  • Safeguarding the Future of Oncology: METAvivor Issues Formal Opposition to Proposed Federal Research Funding Revisions
  • Unveiling the Unexpected: Could Your Everyday Painkiller Hold Anti-Cancer Secrets?
  • The High-Stakes Calculus of Psychedelic Medicine: Definium’s Path to Market
  • Beyond Wrinkles: The Emerging Role of Botox in Revolutionizing Scar Management
  • AI-Powered Imaging Breakthrough: How Altis Labs is Redefining Oncology Clinical Trials

Recent Comments

No comments to show.

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

safeguarding-the-future-of-oncology-metavivor-issues-formal-opposition-to-proposed-federal-research-funding-revisions
  • Patient Advocacy and Support

Safeguarding the Future of Oncology: METAvivor Issues Formal Opposition to Proposed Federal Research Funding Revisions

Pevita Pearce September 19, 2026
unveiling-the-unexpected-could-your-everyday-painkiller-hold-anti-cancer-secrets
  • Medical Research and Clinical Trials

Unveiling the Unexpected: Could Your Everyday Painkiller Hold Anti-Cancer Secrets?

Neng Nana September 19, 2026
the-high-stakes-calculus-of-psychedelic-medicine-definiums-path-to-market
  • Treatment Innovations

The High-Stakes Calculus of Psychedelic Medicine: Definium’s Path to Market

Layla Zulfa September 19, 2026
beyond-wrinkles-the-emerging-role-of-botox-in-revolutionizing-scar-management-1
  • Breast Cancer Surgery and Reconstruction

Beyond Wrinkles: The Emerging Role of Botox in Revolutionizing Scar Management

Sagoh September 19, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.